EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

Sutimlimab shows promise for hard-to-treat, rare blood disorder

In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare c...
Continue Reading →
Europe

First line immunotherapy combination fails to improve overall survival in lung cancer

First line immunotherapy with durvalumab or the combination of durvalumab and tremelimumab does not improve overall survival in unselected patients with lung cancer, ...
Continue Reading →
Europe

Minoryx Therapeutics announces early completion of patient randomization in the ADVANCE trial: a phase 2/3 clinical study of MIN-102 in X-ALD patients

Mataró, Barcelona, Spain, December 12, 2018 – Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announces that i...
Continue Reading →
Europe

Shivom Partners With Lifebit To Power AI-Analysis of DNA Data For Clinical Trials

Blockchain genomics pioneer and AI data analysis firm will provide pharmaceutical organisations and life science users with comprehensive reporting through a library ...
Continue Reading →
Europe

Asarina Pharma Scientific Advisory Board gives full backing to Menstrual Migraine Phase IIA trial

Stockholm – December 18, 2018. On December 17 Asarina Pharma’s Scientific Advisory Board (SAB) gave its full backing to the company’s upcoming trial of a new prevent...
Continue Reading →
Europe

PCI Pharma Services Celebrates Success at Aspire Blaenau Gwent Shared Apprenticeship Awards

Aspire Blaenau Gwent Shared Apprenticeship Programme Award Winners 2018: PCI’s Macauley Webber (back r...
Continue Reading →
Europe

Study: Chemotherapy agent did not improve survival in patients with triple-negative breast cancer

Treating patients who had early-stage triple-negative breast cancer with the chemotherapy agent capecitabine after they completed surgery and standard chemotherapy di...
Continue Reading →
Europe

Liraglutide drug associated with lower risk of cardiovascular events

Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke ...
Continue Reading →
Europe

iDD biotech receives second milestone payment from Genmab with enrollment of fifth patient in GEN1029 (HexaBody®-DR5/DR5) safety trial in patients with malignant solid tumors

Lyon, France, December 4, 2018 – iDD biotech, a French immuno-oncology company with a large pipeline of preclinical and clinical stage monoclonal antibodies, reports ...
Continue Reading →
Europe

Wearable technology could expand electrophysiology market to $2.6bn by 2028, says GlobalData

Following the news that Apple recently announced that 400,000 participants were enrolled in the Apple Heart trial, a study aimed at screening atrial fibrillation, She...
Continue Reading →
Quotient